Some content of this application is unavailable at the moment.
If this situation persist, please contact us atFeedback&Contact
1. (WO2018226177) A SOLUTION FOR PRESERVATION OF ORGANS PRIOR TO ORGAN TRANSPLANTATION
Note: Text based on automatic Optical Character Recognition processes. Please use the PDF version for legal matters

CLAIMS

A solution for preservation of organs prior to organ transplantation used in reducing the damage occurring during transportation and waiting of liver and kidney prior to transplantation, characterized by comprising Raffinose in the range of 25-35 mmol/L, Lactobionate in the range of 80-120 mmol/L, HES (Hydroxy-ethyl starch) in the range of 0-4%g, S042" in the range of 4.5-5.5 mmol/L, Adenosine in the range of 4.5-5.5 mmol/L, Glutathione in the range of 2.7-3.3 mmol/L, Allopurinol in the range of 0.9-1 .1 mmol/l, Na+ in the range of 27-33 mmol/L, K+ in the range of 1 15-125 mmol/L, Mg+ in the range of 4.5-5.5 mmol/L, Histidine/Histidine-HCI in the range of (25-30)/(2.5-3.0) mmol/L, Melatonin in the range of 30-50 mg/L, Glucosamine in the range of 20-100 mg/L.

A solution for preservation of organs prior to organ transplantation according to claim 1 , wherein the solution comprises 30 mmol/L of Raffinose.

A solution for preservation of organs prior to organ transplantation according to claim 1 , wherein the solution comprises 100 mmol/L of Lactobionate.

A solution for preservation of organs prior to organ transplantation according to claim 1 , wherein the solution comprises 5 mmol/L of H2P04".

A solution for preservation of organs prior to organ transplantation according to claim 1 , wherein the solution comprises 20 mmol/L of HP042".

A solution for preservation of organs prior to organ transplantation according to claim 1 , wherein the solution comprises 4% g HES (Hydroxyethyl starch).

A solution for preservation of organs prior to organ transplantation according to claim 1 , wherein the solution comprises 5 mmol/L of S042".

A solution for preservation of organs prior to organ transplantation according to claim 1 , wherein the solution comprises 5 mmol/L of Adenosine.

A solution for preservation of organs prior to organ transplantation according to claim 1 , wherein the solution comprises 3 mmol/L of Glutathione.

10. A solution for preservation of organs prior to organ transplantation according to claim 1 , wherein the solution comprises 1 mmol/L of Allopurinol.

11. A solution for preservation of organs prior to organ transplantation according to claim 1 , wherein the solution comprises 30 mmol/L of Na+.

12. A solution for preservation of organs prior to organ transplantation according to claim 1 , wherein the solution comprises 120 mmol/L of K+.

13. A solution for preservation of organs prior to organ transplantation according to claim 1 , wherein the solution comprises 5 mmol/L of Mg+.

14. A solution for preservation of organs prior to organ transplantation according to claim 1 , wherein the solution comprises 30/3 mmol/L of Histidine/Histidine-HCI.

15. A solution for preservation of organs prior to organ transplantation according to claim 1 , wherein the solution comprises 30 mg/L of Melatonin.

16. A solution for preservation of organs prior to organ transplantation according to claim 1 , wherein the solution comprises 20 mg/L of Glucosamine.

17. A solution for preservation of organs prior to organ transplantation according to claim 1 , wherein the pH of the solution is between 7.35 and 7.45.

18. A solution for preservation of organs prior to organ transplantation according to claim 17, wherein the pH of the solution is 7.4.

19. A solution for preservation of organs prior to organ transplantation according to claim 1 , wherein at least one of H2P04" ve HP042" is used for pH adjustment of the solution for preservation of organs prior to organ transplantation.

20. A solution for preservation of organs prior to organ transplantation according to claim 1 , wherein filters having pores of 0.22 micrometers are used in sterilization.